Get started
Author

Mariangela Caporusso

Observed names: M. Caporusso, MARIANGELA CAPORUSSO, Mariangela CAPORUSSO
ORCID: 0009-0008-7331-3936
Observed ORCID: 0009-0008-7331-3936
OpenAlex ID: A5061744685
The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
2024 · I. Caruso, L. Di Gioia, et al. · Journal of Endocrinological Investigation · 61
PDF
Type 2 Diabetes and Alzheimer’s Disease: The Emerging Role of Cellular Lipotoxicity
2023 · Nicola Marrano, Giuseppina Biondi, et al. · Biomolecules · 44
PDF
Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials
2025 · Sergio Di Molfetta, Ludovico Di Gioia, et al. · Diabetes Obesity and Metabolism · 20
Current evidence on gender-related risk factors for type 1 diabetes, type 2 diabetes and prediabetes: a reappraisal of the Italian study group on gender difference in endocrine diseases
2024 · Giovanna Muscogiuri, Mariangela Caporusso, et al. · Journal of Endocrinological Investigation · 11
Pharmacological Management of Diabesity: Current and Emerging Therapies
2026 · Martina Galasso, Mariangela Caporusso, et al. · Current Obesity Reports · 6
Diabetic foot: clinical approach
2022 · Irene CARUSO, Anna LEONARDINI, et al. · Minerva Orthopedics · 6
Efficacy and Safety of Automated Insulin Delivery in People With Type 2 Diabetes: A Systematic Review and Meta‐Analysis
2026 · Sergio Di Molfetta, Ludovico Di Gioia, et al. · Diabetes Obesity and Metabolism · 5
Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitors
2025 · Nicola Marrano, Mariangela Caporusso, et al. · Journal of Endocrinological Investigation · 5
PDF
Efficacy and Safety of Different Commercially Available Hybrid Closed-Loop Systems in People with Type 1 Diabetes: An up to Date Systematic Review with Meta-Analysis and Network Meta-Analysis
2026 · Sergio Di Molfetta, Ludovico Di Gioia, et al. · Diabetes Technology and Obesity Medicine · 4
Efficacy and safety of once‐weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta‐analysis
2025 · Ludovico Di Gioia, Sergio Di Molfetta, et al. · Diabetes Obesity and Metabolism · 3
PDF
Fulminant pheochromocytoma crisis triggered by glucocorticoids: ultra-early adrenalectomy under ECMELLA support
2026 · Ludovico Di Gioia, Emanuele Rollo, et al. · Frontiers in Endocrinology · 2
Implicazioni cliniche extraglicemiche dell’insulino-resistenza
2022 · Mariangela Caporusso, Sebastio Perrini, et al. · L Endocrinologo · 1
PDF
1061-P: Need for Insulin Therapy in Gestational Diabetes Mellitus: A Predictive Model Assessment
2022 · MARIANGELA CAPORUSSO, LUDOVICO DI GIOIA, et al. · Diabetes · 1
Impact of baricitinib on thyroid function and autoimmunity in severe alopecia areata: A pilot study
2026 · Francesca Ambrogio, Ludovico Di Gioia, et al. · Journal of the European Academy of Dermatology and Venereology
PDF
Impatto della surrenectomia e della terapia con antagonisti del recettore dei mineralcorticoidi sul rimodellamento ventricolare sinistro nell’iperaldosteronismo primitivo: revisione sistematica e meta-analisi
2026 · Ludovico Di Gioia, Mariangela Caporusso, et al. · L Endocrinologo
Author response for "Efficacy and safety of closed-loop insulin delivery in people with type 2 diabetes: a systematic review and meta-analysis"
2026 · Sergio Di Molfetta, Ludovico Di Gioia, et al. · Publons reviews and discussion
The Real-World Endocrine Toxicity Profile of ICIs, VEGFR-TKIs, and Their Combination: Analysis of the FDA Adverse Event Reporting System (FAERS) Database
2026 · Nicola Marrano, Mariangela Caporusso, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
PDF
Efficacy and Safety of Tirzepatide in Refractory Hypoglycemia Associated with Esophagojejunostomy
2025 · Mariangela Caporusso, Ludovico Di Gioia, et al. · JCEM Case Reports
PDF
Author response for "Efficacy and safety of once‐weekly basal insulin therapy in people with type 1 diabetes: A systematic review and meta‐analysis"
2025 · Ludovico Di Gioia, Sergio Di Molfetta, et al. · Publons reviews and discussion
Author response for "Glycaemic control and variability with different commercially available hybrid closed loop systems in people with type 1 diabetes: A systematic review and meta‐analysis of randomized controlled trials"
2025 · Sergio Di Molfetta, Ludovico Di Gioia, et al. · Publons reviews and discussion
Strumenti per valutare l’aderenza al trattamento insulinico nel diabete mellito
2025 · Ludovico Di Gioia, Mariangela Caporusso, et al. · L Endocrinologo
Effetti dei nuovi farmaci incretinici sulla salute dell’osso
2024 · Gian Pio Sorice, Mariangela Caporusso, et al. · L Endocrinologo
PDF
981-P: Transition from Standard Time to Daylight Saving Time and Vice Versa—Effects on FGM Metrics in Patients with Autoimmune Diabetes
2023 · LUDOVICO DI GIOIA, SERGIO DI MOLFETTA, et al. · Diabetes
Fattori predittivi per l’inizio della terapia insulinica nel diabete gestazionale
2023 · Mariangela Caporusso, Angelo Cignarelli, et al. · L Endocrinologo
PDF
Metformin use in pregnancy: efficacy, safety, and potential benefits
2022 · G. P. Sorice, M. Caporusso, et al. · Journal of Endocrinological Investigation
Works count: 26
Citation count: 169
H-index: 6
I10-index: 4
Year
Topic
Type